CoChat
Sign Up
Cited by 153Schizophrenia research and treatmentPituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth Factors

The DOI matches its Crossref record; 183 of the 184 references it cites were found in a registry or an index.

Clinical Implications of Antipsychotic-Induced Hyperprolactinemia in Patients With Schizophrenia Spectrum or Bipolar Spectrum Disorders: Recent Developments and Current Perspectives

Byerly, Matthew, Suppes, Trisha, Tran, Quynh-Van, Baker, Ross A.·2007·Journal of Clinical Psychopharmacology
DOI 10.1097/jcp.0b013e31815ac4e5
Open this paper in CoChat — free account

Abstract

Hyperprolactinemia is increasingly studied as a frequent and potentially important consequence of antipsychotic medication treatment. Some individuals presenting with hyperprolactinemia remain asymptomatic, but others may exhibit a wide range of clinical symptoms resulting from either the direct effects of prolactin on body tissues (galactorrhea, gynecomastia) or endocrine-related secondary effects (sexual and reproductive dysfunction in the short term, and possibly the risk of tumorigenesis and osteoporosis in the longer term). Short-term side effects may negatively impact medication compliance, and long-term effects have the potential for serious health consequences. Antipsychotic medications have differing propensities to cause prolactin elevation. The first-generation antipsychotics, as well as the second-generation antipsychotic risperidone and its active metabolite paliperidone, have been shown to cause marked and sustained elevations in prolactin levels, whereas others of the second-generation antipsychotics appear to have little or no effect on prolactin levels or may decrease prolactin. A comprehensive overview of antipsychotics and hyperprolactinemia is presented together with a review of emerging evidence about the short- and long-term health risks of hyperprolactinemia.

Overview

Integrity signals

Registry

Crossref · 10.1097/jcp.0b013e31815ac4e5

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 184 references

Research works printed but not linked: 3

  1. Cook, 1992, Pediatric reference ranges for prolactin., Clin Chem, 38, 959
  2. Kaneda, 2000, Neither gynaecomastia nor galactorrhea is a common side effect of neuroleptics in male patients., Neuroendocrinol Lett, 21, 447
  3. Ansbacher, 1990, Variability of serum prolactin and progesterone levels in normal women: the relevance of single hormone measurements in the clinical setting., Obstet Gynecol, 76, 895

Cited by

Sorted by citations

Items 101–153 of 153

Related

See all

Metadata

Authors
Byerly, M., Suppes, T., Tran, Q.-V., & Baker, R. A.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Otsuka (United States) (US)
  • Bristol-Myers Squibb (United States) (US)
Corresponding author
  • Byerly, Matthew
  • Suppes, Trisha
ORCID
Venue
Journal of Clinical Psychopharmacology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2007-12
Volume
27
Issue
6
Pages
639-661
ISSN
0271-0749 (ISSN-L)
DOI
10.1097/jcp.0b013e31815ac4e5
OpenAlex
W1965091910
Cited by
153
References
184
Citations by year
2026: 7 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 3 · 2019: 3 · 2018: 7 · 2017: 10 · 2016: 10 · 2015: 11 · 2014: 11 · 2013: 10 · 2012: 9
FWCI
1.56
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
antipsychotic-induced hyperprolactinemia, schizophrenia spectrum disorders, bipolar spectrum disorders, typical antipsychotics, atypical antipsychotics, risperidone, paliperidone, galactorrhea, gynecomastia, sexual dysfunction, reproductive disorders, carcinogenesis, osteoporosis, medication adherence, long-term health risks
MeSH terms
Bipolar Disorder, Humans, Hyperprolactinemia, Models, Biological, Psychopharmacology, Schizophrenia, Antipsychotic Agents, Meta-Analysis as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review